Benjamin Levy, MD

Dr. Levy is Assistant Professor at the Johns Hopkins School of Medicine and recently recruited to be Clinical Director of The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Medicine at Sibley Hospital in Washington DC. Prior to his Hopkins appointment, Dr Levy was Medical Director of Thoracic Oncology Program for Mount Sinai Health Systems in NYC and Associate Director of the Cancer Clinical Trials Office (CCTO). Dr Levy is a clinical researcher who is currently leading global immunotherapy trials evaluating checkpoint point inhibitors with novel combination strategies. He also remains interested in the therapeutic value of repurposed therapies like metformin in lung cancer and the genetic alterations that predict sensitivity to such agents. Dr. Levy has played an integral role on several ASCO committees and currently serves as Editor in Chief of the ASCO SEP Book and Associate Editor for the ASCO University Committee, a committee whose mission is to develop and distribute web based educational content to oncologists around the country. He recently completed a two term on the editorial board for the Journal of Clinical Oncology (JCO) and currently serves as an ad hoc reviewer for other journals including Clinical Lung Cancer and The Oncologist. He was recently selected as one of only 15 oncologist in the country to the prestigious ASCO Leadership Development Program whose mission is to identify and develop future leaders of ASCO. It addition to his ASCO commitments, Dr. Levy serves on the IASLC Staging Committee and IASLC Career Development & Fellowship Committee.